Last reviewed · How we verify
NCT02830789
Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass in Order to Treat Secondary Hyperparathyroidism: A Clinical Randomized Trial
NA trial testing Calcium Carbonate in Roux-en-Y Gastric Bypass in 38 participants. Completed in 1 May 2017.
1 May 2017
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 1 December 2016 |
| Primary completion | 1 May 2017 |
| Estimated completion | 1 May 2017 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Calcium Carbonate (calcium carbonate) — full drug profile →
- Calcium Citrate — full drug profile →
- Placebo
- Roux-en-Y gastric bypass
Conditions studied
- Roux-en-Y Gastric Bypass — all drugs for Roux-en-Y Gastric Bypass →
- Hyperparathyroidism, Secondary — all drugs for Hyperparathyroidism, Secondary →
Sponsor
University of Aarhus
Who can join
Adults 20 to 70, any sex, with Roux-en-Y Gastric Bypass or Hyperparathyroidism, Secondary. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Parathyroid Hormone
Time frame: Change from baseline at 6 weeks and 12 weeks
Sponsor's own description
This study investigates whether calcium citrate or calcium carbonate are the optimal supplement to treat secondary hyperparathyroidism following Roux-en-Y gastric bypass operation. Half of the participants will be randomized to receive calcium citrate, while the other half will receive calcium carbonate. The study will be double blinded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02830789
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium Carbonate
Trials testing the same drug.
- NCT06352775 — Calcium Carbonate on Labor Induction · NA · active not recruiting
- NCT03634917 — Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test fo · Phase 3 · completed
- NCT04550078 — The Postprandial Calcium Absorption of a Milk Derived Calcium Permeate - RENEW Acute Study · NA · completed
- NCT03425747 — Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism · Phase 4 · completed
- NCT05109390 — A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adu · Phase 1 · completed
Other recruiting trials for Roux-en-Y Gastric Bypass
Currently open trials in the same condition.
- NCT04808206 — A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy · active not recruiting
- NCT04422236 — A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Sur · active not recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02830789 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 23 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02830789.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing